Ionis Pharmaceuticals, Inc.
(NASDAQ : ISIS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.78%150.260.0%$1872.72m
NVAXNovavax, Inc. -3.99%230.3792.9%$1438.06m
OCGNOcugen, Inc. -9.85%8.050.0%$872.04m
AMGNAmgen, Inc. -1.26%227.101.3%$590.73m
ILMNIllumina, Inc. -4.04%442.423.5%$547.01m
REGNRegeneron Pharmaceuticals, Inc. -1.59%451.332.7%$524.49m
VRTXVertex Pharmaceuticals, Inc. -2.38%211.881.9%$506.56m
GILDGilead Sciences, Inc. -1.52%62.741.0%$492.77m
BNGOBioNano Genomics, Inc. -8.89%10.190.0%$440.81m
ALXNAlexion Pharmaceuticals, Inc. -0.60%153.572.0%$389.08m
BIIBBiogen, Inc. -2.33%276.141.7%$375.75m
CRSPCRISPR Therapeutics AG -3.59%128.730.6%$307.43m
SRNESorrento Therapeutics, Inc. -5.29%10.391.3%$251.87m
EXASEXACT Sciences Corp. -3.65%129.9018.4%$249.99m
VXRTVaxart, Inc. 5.25%7.730.0%$234.70m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.